C D McFaul*
, W Greenhalf*, J Earl, N Howes, J P Neoptolemos,
Division of Surgery and Oncology, University of Liverpool, Liverpool, UK
R Kress, Institute of Medical Biometry and Epidemiology, Philipps-
University, Marburg, Germany
M Sina-Frey, H Rieder, D K Bartsch, Department of Clinical Genetics,
Philipps-University, Marburg, Germany
S Hahn, Department of Internal Medicine, Knappschaftskrankenhaus
University of Bochum, Bochum, Germany
*C D McFaul and W Greenhalf contributed equally as principal
Conflict of interest: None declared.
1 Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical
conditions and familial history of cancer as risk factors for pancreatic cancer.
Br J Cancer 1999;80:1830–7.
2 Hemminki K, Li X. Familial and second primary pancreatic cancers: a
nationwide epidemiologic study from Sweden. Int J Cancer
3 Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer
in familial pancreatic cancer kindreds. Cancer Res 2004;64:2634–8.
4 Bartsch DK, Kress R, Sina-Frey M, et al. Prevalence of familial pancreatic
cancer in Germany. Int J Cancer 2004;110:902–6.
5 Giardiello FM, Offerhaus GJ, Lee DH, et al. Increased risk of thyroid and
pancreatic carcinoma in familial adenomatous polyposis. Gut
6 The Breast Cancer Linkage Consortium: Cancer risks in BRCA2 mutation
carriers. J Natl Cancer Inst 1999;91:1310–16.
7 Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in
familial Peutz-Jeghers syndrome. Gastroenterology 2000;119:1447–53.
8 Bartsch DK, Sina-Frey M, Lang S, et al. CDKN2A germline mutations in
familial pancreatic cancer. Ann Surg 2002;236:730–7.
9 Lynch HT, Brand RE, Hogg D, et al. Phenotypic variation in eight extended
CDKN2A germline mutation familial atypical multiple mole melanoma-
pancreatic carcinoma-prone families: the familial atypical mole melanoma-
pancreatic carcinoma syndrome. Cancer 2002;94:84–96.
10 Klein AP, Beaty TH, Bailey-Wilson JE, et al. Evidence for a major gene
influencing risk of pancreatic cancer. Genet Epidemiol 2002;23:133–49.
11 Hahn SA, Greenhalf B, Ellis I, et al. BRCA2 germline mutations in familial
pancreatic carcinoma. J Natl Cancer Inst 2003;95:214–21.
12 Eberle MA, Pfutzer R, Pogue-Geile KL, et al. A new susceptibility locus for
autosomal dominant pancreatic cancer maps to chromosome 4q32-34.
Am J Hum Genet 2002;70:1044–8.
13 Sutherland GR, Richards RI. Simple tandem DNA repeats and human genetic
disease. Proc Natl Acad Sci U S A 1995;92:3636–41.
14 Kehoe P, Krawczak M, Harper PS, et al. Age of onset in Huntington disease:
sex specific influence of apolipoprotein E genotype and normal CAG repeat
length. J Med Genet 1999;36:108–11.
15 Grandbastien B, Peeters M, Franchimont D, et al. Anticipation in familial
Crohn’s disease. Gut 1998;42:170–4.
16 Annese V, Andreoli A, Astegiano M, et al. Clinical features in familial cases of
Crohn’s disease and ulcerative colitis in Italy: a GISC study. Italian Study
Group for the Disease of Colon and Rectum. Am J Gastroenterol
17 Radstake TR, Barrera P, Albers MJ, et al. Genetic anticipation in rheumatoid
arthritis in Europe. European Consortium on Rheumatoid Arthritis Families.
J Rheumatol 2001;28:962–7.
18 Paterson AD, Kennedy JL, Petronis A. Evidence for genetic anticipation in non-
Mendelian diseases. Am J Hum Genet 1996;59:264–8.
19 Siegel AM, Andermann F, Badhwar A, et al. Anticipation in familial
cavernous angioma: ascertainment bias or genetic cause. Acta Neurol Scand
20 De Lord C, Powles R, Mehta J, et al. Familial acute myeloid leukaemia: four
male members of a single family over three consecutive generations exhibiting
anticipation. Br J Haematol 1998;100:557–60.
21 Horwitz M, Goode EL, Jarvik GP. Anticipation in familial leukemia. Am J Hum
22 Yuille MR, Houlston RS, Catovsky D. Anticipation in familial chronic
lymphocytic leukaemia. Leukemia 1998;12:1696–8.
23 Wiernik PH, Wang SQ, Hu XP, et al. Age of onset evidence for anticipation in
familial non-Hodgkin’s lymphoma. Br J Haematol 2000;108:72–9.
24 Shugart YY, Hemminki K, Vaittinen P, et al. A genetic study of Hodgkin’s
lymphoma: an estimate of heritability and anticipation based on the familial
cancer database in Sweden. Hum Genet 2000;106:553–6.
25 Shugart YY, Hemminki K, Vaittinen P, et al. Apparent anticipation and
heterogeneous transmission patterns in familial Hodgkin’s and non-Hodgkin’s
lymphoma: report from a study based on Swedish cancer database. Leuk
26 Goldstein AM, Clark WH Jr, Fraser MC, et al. Apparent anticipation in
familial melanoma. Melanoma Res 1996;6:441–6.
27 Wong T, Howes N, Threadgold J, et al. Molecular diagnosis of early
pancreatic ductal adenocarcinoma in high risk patients. Pancreatology
28 Rulyak SJ, Kimmey MB, Veenstra DL, et al. Cost-effectiveness of pancreatic
cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc
29 Rieder H, Sina-Frey M, Ziegler A, et al. German national case collection of
familial pancreatic cancer—clinical-genetic analysis of the first 21 families.
30 Rulyak SJ, Lowenfels AB, Maisonneuve P, et al. Risk factors for the
development of pancreatic cancer in familial pancreatic cancer kindreds.
31 Tsai YY, Petersen GM, Booker SV, et al. Evidence against genetic anticipation
in familial colorectal cancer. Genet Epidemiol 1997;14:435–46.
32 Faybush EM, Blanchard JF, Rawsthorne P, et al. Generational differences in
the age at diagnosis with Ibd: genetic anticipation, bias, or temporal effects.
Am J Gastroenterol 2002;97:636–40.
33 Fraser FC. Trinucleotide repeats not the only cause of anticipation. Lancet
34 Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics
of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol
35 Hsu L, Zhao LP, Malone KE, et al. Assessing changes in ages at onset over
successive generation: an application to breast cancer. Genet Epidemiol
36 Picco MF, Goodman S, Reed J, et al. Methodologic pitfalls in the
determination of genetic anticipation: the case of Crohn disease. Ann Intern
37 Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560
patients with pancreatic cancer, and incidence of the disease, in the West
Midlands: an epidemiological study. Br J Surg 1995;82:111–15.
38 Nitecki SS, Sarr MG, Colby TV, et al. Long-term survival after resection for
ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg
39 Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of
treatment and survival trends for 100,313 patients diagnosed from 1985–
1995, using the National Cancer Database. J Am Coll Surg 1999;189:1–7.
40 Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and
death after pancreaticoduodenectomy: risk factors and the impact of hospital
volume. Ann Surg 2000;232:786–95.
41 Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global
picture. Eur J Cancer 2001;37(suppl 8):4–66.
42 Hruban RH, Canto MI, Yeo CJ. Prevention of pancreatic cancer and strategies
for management of familial pancreatic cancer. Dig Dis 2001;19:76–84.
43 Coughlin SS, Calle EE, Patel AV, et al. Predictors of pancreatic cancer
mortality among a large cohort of United States adults. Cancer Causes Control
44 Boyle P, Maisonneuve P, Bueno de Mesquita B, et al. Cigarette smoking and
pancreas cancer: a case control study of the search programme of the IARC.
Int J Cancer 1996;67:63–71.
45 Kemm JR. A birth cohort analysis of smoking by adults in Great Britain 1974–
1998. J Public Health Med 2001;23:306–11.
46 Trkova M, Hladikova M, Kasal P, et al. Is there anticipation in the age at onset
of cancer in families with Li-Fraumeni syndrome? J Hum Genet
47 Paterson AD, Naimark DM, Huang J, et al. Genetic anticipation and breast
cancer: a prospective follow-up study. Breast Cancer Res Treat
48 McInnis MG. Anticipation: an old idea in new genes. Am J Hum Genet
49 Petronis A, Kennedy JL, Paterson AD. Genetic anticipation: fact or artifact,
genetics or epigenetics? Lancet 1997;350:1403–4.
50 Thorlacius S, Sigurdsson S, Bjarnadottir H, et al. Study of a single BRCA2
mutation with high carrier frequency in a small population. Am J Hum Genet
51 Dagan E, Gershoni-Baruch R. Anticipation in hereditary breast cancer. Clin
258 McFaul, Greenhalf, Earl, et al